{
    "2018-05-17": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Investors Need to Adopt a Different Mindset for Big Pharma and Biotech Stocks",
                "features": {
                    "keywords": [
                        "investors",
                        "mindset",
                        "big pharma",
                        "biotech"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-04-20",
                "original_text": "Why Is Johnson & Johnson (JNJ) Down 4.1% Since its Last Earnings Report?",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "earnings report",
                        "down"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-05-10",
                "original_text": "How To Get Quality In The Core",
                "features": {
                    "keywords": [
                        "quality",
                        "core"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-06-05",
                "original_text": "Taking Stock of Gilead Sciences’ Key Developments",
                "features": {
                    "keywords": [
                        "Gilead Sciences",
                        "key developments"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-09",
                "original_text": "Novartis Gains Ground, Completes the AveXis Acquisition",
                "features": {
                    "keywords": [
                        "Novartis",
                        "AveXis",
                        "acquisition"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-08-12",
                "original_text": "3 Growth Stocks to Buy and Hold for the Next 50 Years",
                "features": {
                    "keywords": [
                        "growth stocks",
                        "buy",
                        "hold"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-09-25",
                "original_text": "Gilead Sciences’ Cash Flows, Valuations, and Price Performance",
                "features": {
                    "keywords": [
                        "Gilead Sciences",
                        "cash flows",
                        "valuations",
                        "price performance"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-15",
                "original_text": "Why law school may be the next step for this recently retired health care CEO",
                "features": {
                    "keywords": [
                        "law school",
                        "retired",
                        "health care",
                        "CEO"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-11-20",
                "original_text": "Jim Cramer Shares His Thoughts On Johnson & Johnson, Nike And More",
                "features": {
                    "keywords": [
                        "Jim Cramer",
                        "Johnson & Johnson",
                        "Nike"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "consumer goods"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}